Why does it matter?
As of 2019 8.5 million people were living with Parkinson's Disease
If we can diagnose PD early and start managing the disease, we will improve the quality of life of people living with the disease. There are signs, but we ignore them.
"There is no unified system to help neurologists communicate with physiotherapists and other community healthcare professionals. They rely on the NHS letters shared by patients".
- Our interview with a PD physiotherapist
High Latency in PD diagnostics
18 to 22 months for a definitive diagnosis
AI-driven diagnosis
Our Medtech will capture key signals and use AI to offer a clinical decision support system
Fragmented diagnostic pathway
The system isn't broken, it doesn't exist. People need a reliable one-stop solution
SaaS and EHR integration
We can offer SaaS for routine neurological monitoring and a clinical decision support system integrated with your existing Electronic Health Records
Current solutions are not cost or time efficient
A costly one-time solution is not the answer to chronic disease management.
Industrial Partnerships
We want to partner with pharmaceutical companies working on early stage parkinson medication. We can serve as a validation tool for prognostic monitoring